Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-09-20

Clinical Trial Update: PET/CT Scans Using the Tracer 11C-Csar, a Bile Acid Analog, to Depict and Visualize Changes in the Hepatobiliary System in Patients With Primary Biliary Cholangitis Before and After Treatment.

View source ↗

Summary

An ongoing clinical trial update evaluating the 11C-Csar tracer, a bile acid analog, to image hepatobiliary changes in Primary Biliary Cholangitis before and af…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 11C-Csar tracer (bile acid analog) (11C-Csar)

Snippet

Sponsor: University of Aarhus | Conditions: Primary Biliary Cholangitis (PBC), Cirrhosis | Status: ACTIVE_NOT_RECRUITING